Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry

Journal of Virology

Volumn 87, Issue 13, 2013, Pages 7765-7773

  Spoden, Gilles ^a   Kühling, Lena ^b   Cordes, Nicole ^b   Frenzel, Bettina ^a   Sapp, Martin ^c   Boller, Klaus ^d   Florin, Luise ^a   Schelhaas, Mario ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; CD151 ANTIGEN; CLATHRIN; DYNAMIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1;

ACTIN POLYMERIZATION; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; LIPID RAFT; MOLECULAR MECHANICS; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; VIRION; VIRUS ENTRY;

ACTINS; ANTIGENS, CD151; DYNAMIN II; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOCYTOSIS; HELA CELLS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 31; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MEMBRANE MICRODOMAINS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; POLYMERIZATION; VIRUS INTERNALIZATION;

EID: 84880351887     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00370-13     Document Type: Article

References (49)

1. Longworth MS, Laimins LA. 2004. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68:362-372.
2. Schelhaas M. 2010. Come in and take your coat off-how host cells provide endocytosis for virus entry. Cell Microbiol. 12:1378-1388.
3. Mercer J, Schelhaas M, Helenius A. 2010. Virus entry by endocytosis. Annu. Rev. Biochem. 79:803-833.
4. Doherty GJ, McMahon HT. 2009. Mechanisms of endocytosis. Annu. Rev. Biochem. 78:857-902.
5. Hindmarsh PL, Laimins LA. 2007. Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol. J. 4:19. doi:10.1186/1743-422X-4-19.
6. Day PM, Lowy DR, Schiller JT. 2003. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307:1-11.
7. Bousarghin L, Touze A, Sizaret PY, Coursaget P. 2003. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J. Virol. 77:3846-3850.
8. Laniosz V, Dabydeen SA, Havens MA, Meneses PI. 2009. Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin A sensitive. J. Virol. 83:8221-8232.
9. Schelhaas M, Shah B, Holzer M, Blattmann P, Kuhling L, Day PM, Schiller JT, Helenius A. 2012. Entry of human papillomavirus type 16 by actin-dependent, clathrinand lipid raft-independent endocytosis. PLoS Pathog. 8:e1002657. doi:10.1371/journal.ppat.1002657.
10. Spoden G, Freitag K, Husmann M, Boller K, Sapp M, Lambert C, Florin L. 2008. Clathrinand caveolin-independent entry of human papillomavirus type 16-involvement of tetraspanin-enriched microdomains (TEMs). PLoS One 3:e3313. doi:10.1371/journal.pone.0003313.
11. Scheffer KD, Gawlitza A, Spoden GA, Zhang XA, Lambert C, Berditchevski F, Florin L. 2013. Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J. Virol. 87:3435-3446.
12. Smith JL, Campos SK, Ozbun MA. 2007. Human papillomavirus type 31 uses a caveolin 1and dynamin 2-mediated entry pathway for infection of human keratinocytes. J. Virol. 81:9922-9931.
13. Buck CB, Pastrana DV, Lowy DR, Schiller JT. 2005. Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol. Med. 119:445-462.
14. Buck CB, Pastrana DV, Lowy DR, Schiller JT. 2004. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 78:751-757.
15. Spoden GA, Besold K, Krauter S, Plachter B, Hanik N, Kilbinger AF, Lambert C, Florin L. 2012. Polyethylenimine is a strong inhibitor of human papillomavirus and cytomegalovirus infection. Antimicrob. Agents Chemother. 56:75-82.
16. Knappe M, Bodevin S, Selinka HC, Spillmann D, Streeck RE, Chen XS, Lindahl U, Sapp M. 2007. Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate. J. Biol. Chem. 282:27913-27922.
17. Volpers C, Sapp M, Snijders PJ, Walboomers JM, Streeck RE. 1995. Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid protein L2. J. Gen. Virol. 76(Pt 11):2661-2667.
18. Volpers C, Sapp M, Komly CA, Richalet-Secordel P, Streeck RE. 1993. Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33. J. Virol. 67:19271935.
19. Sapp M, Kraus U, Volpers C, Snijders PJ, Walboomers JM, Streeck RE. 1994. Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. J. Gen. Virol. 75(Pt 12):3375-3383.
20. Culp TD, Christensen ND. 2004. Kinetics of in vitro adsorption and entry of papillomavirus virions. Virology 319:152-161.
21. Selinka HC, Giroglou T, Sapp M. 2002. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 299: 279-287.
22. Selinka HC, Florin L, Patel HD, Freitag K, Schmidtke M, Makarov VA, Sapp M. 2007. Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J. Virol. 81:10970-10980.
23. Schneider MA, Spoden GA, Florin L, Lambert C. 2011. Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol. 13:32-46.
24. Wang LH, Rothberg KG, Anderson RG. 1993. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 123:1107-1117.
25. Elferink JG. 1979. Chlorpromazine inhibits phagocytosis and exocytosis in rabbit polymorphonuclear leukocytes. Biochem. Pharmacol. 28:965968.
26. Watanabe S, Hirose M, Miyazaki A, Tomono M, Takeuchi M, Kitamura T, Namihisa T. 1988. Calmodulin antagonists inhibit the phagocytic activity of cultured Kupffer cells. Lab. Invest. 59:214-218.
27. Amyere M, Payrastre B, Krause U, Van Der Smissen P, Veithen A, Courtoy PJ. 2000. Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C. Mol. Biol. Cell 11:34533467.
28. Giocondi MC, Mamdouh Z, Le Grimellec C. 1995. Benzyl alcohol differently affects fluid phase endocytosis and exocytosis in renal epithelial cells. Biochim. Biophys. Acta 1234:197-202.
29. Benmerah A, Lamaze C, Begue B, Schmid SL, Dautry-Varsat A, CerfBensussan N. 1998. AP-2/Eps15 interaction is required for receptormediated endocytosis. J. Cell Biol. 140:1055-1062.
30. Marsh M, Helenius A. 1980. Adsorptive endocytosis of Semliki Forest virus. J. Mol. Biol. 142:439-454.
31. Schlegel R, Willingham MC, Pastan IH. 1982. Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells. J. Virol. 43:871-875.
32. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A. 2005. Clathrinand caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168:477488.
33. Hayer A, Stoeber M, Ritz D, Engel S, Meyer HH, Helenius A. 2010. Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J. Cell Biol. 191:615-629.
34. Smith JL, Campos SK, Wandinger-Ness A, Ozbun MA. 2008. Caveolin1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. J. Virol. 82:9505-9512.
35. Sieczkarski SB, Whittaker GR. 2002. Dissecting virus entry via endocytosis. J. Gen. Virol. 83:1535-1545.
36. Marsh M, Bolzau E, Helenius A. 1983. Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell 32:931-940.
37. Loerke D, Mettlen M, Yarar D, Jaqaman K, Jaqaman H, Danuser G, Schmid SL. 2009. Cargo and dynamin regulate clathrin-coated pit maturation. PLoS Biol. 7:e57. doi:10.1371/journal.pbio.1000057.
38. Cureton DK, Massol RH, Saffarian S, Kirchhausen TL, Whelan SP. 2009. Vesicular stomatitis virus enters cells through vesicles incompletely coated with clathrin that depend upon actin for internalization. PLoS Pathog. 5:e1000394. doi:10.1371/journal.ppat.1000394.
39. Schelhaas M, Ewers H, Rajamaki ML, Day PM, Schiller JT, Helenius A. 2008. Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog. 4:e1000148. doi:10.1371 /journal.ppat.1000148.
40. Pelkmans L, Helenius A. 2002. Endocytosis via caveolae. Traffic 3:311320.
41. Schiller JT, Day PM, Kines RC. 2010. Current understanding of the mechanism of HPV infection. Gynecol. Oncol. 118:S12-S17.
42. Florin L, Sapp M, Spoden GA. 2012. Host-cell factors involved in papillomavirus entry. Med. Microbiol. Immunol. 201:437-448.
43. Fligge C, Schafer F, Selinka HC, Sapp C, Sapp M. 2001. DNA-induced structural changes in the papillomavirus capsid. J. Virol. 75:7727-7731.
44. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT. 2005. Maturation of papillomavirus capsids. J. Virol. 79:2839-2846.
45. Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC, Schiller JT, Trus BL. 2008. Arrangement of L2 within the papillomavirus capsid. J. Virol. 82:5190-5197.
46. Boucheix C, Rubinstein E. 2001. Tetraspanins. Cell. Mol. Life Sci. 58: 1189-1205.
47. Yunta M, Lazo PA. 2003. Tetraspanin proteins as organisers of membrane microdomains and signalling complexes. Cell Signal. 15:559-564.
48. Hemler ME. 2001. Specific tetraspanin functions. J. Cell Biol. 155:1103-1107.
49. Yanez-Mo M, Barreiro O, Gordon-Alonso M, Sala-Valdes M, SanchezMadrid F. 2009. Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol. 19:434-446.